Demecarium bromide: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
<div style="float: right;"> | <div style="float: right;"> | ||
[[File:Demecarium.png|thumb|none|400px|This image is provided by the National Library of Medicine.]]</div> | [[File:Demecarium.png|thumb|none|400px|This image is provided by the National Library of Medicine.]]</div> | ||
__NOTOC__ | __NOTOC__ | ||
{{SI}} | {{SI}} | ||
{{CMG}} | {{CMG}} | ||
| Line 19: | Line 16: | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Quaternary ammonium compounds]] | [[Category:Quaternary ammonium compounds]] | ||
[[Category:Carbamates]] | [[Category:Carbamates]] | ||
[[Category:Drug]] | [[Category:Drug]] | ||
Latest revision as of 15:14, 7 April 2015
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Demecarium is a parasympathomimetic that acts as an acetylcholinesterase inhibitor. It is one of several topical (applied directly to the affected area) medications used to reduce elevated intraocular pressure (IOP) associated with primary glaucoma in cats, dogs, and other animals.[1][2][3]
See also
References
- ↑ Ward D, Abney K, Oliver J (2003). "The effects of topical ocular application of 0.25% demecarium bromide on serum acetylcholinesterase levels in normal dogs". Vet Ophthalmol. 6 (1): 23–5. doi:10.1046/j.1463-5224.2003.00257.x. PMID 12641839.
- ↑ Krohne S (1994). "Effect of topically applied 2% pilocarpine and 0.25% demecarium bromide on blood-aqueous barrier permeability in dogs". Am J Vet Res. 55 (12): 1729–33. PMID 7887518.
- ↑ Gum G, Gelatt K, Gelatt J, Jones R (1993). "Effect of topically applied demecarium bromide and echothiophate iodide on intraocular pressure and pupil size in beagles with normotensive eyes and beagles with inherited glaucoma". Am J Vet Res. 54 (2): 287–93. PMID 8430939.